Hainan Tongyong Tongmeng Pharmaceutical

Hainan Tongyong Tongmeng Pharmaceutical Co., Ltd. (also known as Hainan GT-Unipul Pharmaceutical) is a Chinese pharmaceutical company founded in 2001 and based in Haikou, Hainan. The company specializes in the research, development, manufacturing, and commercialization of chemical synthetic drugs, active pharmaceutical ingredients (APIs), and biological products. Its product portfolio spans multiple therapeutic areas, including oncology, cardiovascular diseases, neurology, and infectious diseases, with key products such as exemestane tablets (YiSiTan) for breast cancer, low-molecular-weight heparin calcium for thrombosis, and brain protein hydrolysate (Cerebrolysin Vial) for cerebrovascular disorders. Hainan Tongyong Tongmeng operates advanced manufacturing facilities that comply with GMP standards and has established a comprehensive marketing and distribution network across China.